HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.
Título
HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.
Autor
Irene Bonaccorsi, Paolo Carrega, Emmanuele Venanzi Rullo, Rosaria Ducatelli, Michela Falco, Josè Freni, Massimiliano Miceli, Riccardo Cavaliere, Vincenzo Fontana, Antonio Versace, Gaetano Caramori, Antonio David, Giuseppe Nunnari, Guido Ferlazzo
Fecha
2021
Materia
HLA, covid-19, Troponin-T, KIR, CD8+ cytotoxic T cells, Cardiovascular, SARS-CoV-2
Identificador
10.1016/j.imlet.2021.04.007
Fuente
Immunology letters
Archivos
Colección
Citación
Irene Bonaccorsi, Paolo Carrega, Emmanuele Venanzi Rullo, Rosaria Ducatelli, Michela Falco, Josè Freni, Massimiliano Miceli, Riccardo Cavaliere, Vincenzo Fontana, Antonio Versace, Gaetano Caramori, Antonio David, Giuseppe Nunnari, Guido Ferlazzo, “HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/8967.
Position: 7999 (28 views)